Sankt Gorans Sjukhus

Oncology and Breast Cancer Research

At Sankt Gorans Sjukhus, oncology trials are strongly centered on breast cancer, including early, non-metastatic, and advanced disease. The studies explore new treatment combinations and personalized approaches aimed at improving response, reducing recurrence, and supporting longer-term outcomes.

Neoadjuvant and adjuvant strategies for early breast cancer and triple-negative breast cancer
Targeted and biomarker-informed approaches for HER2-positive and ER-positive disease
Research designed to improve treatment effectiveness and reduce the risk of cancer returning

This work includes efforts to refine personalized oncology and identify better treatment options for patients with high-risk or treatment-resistant disease.

Prostate Cancer and Genitourinary Studies

The site also supports clinical research in prostate cancer and related genitourinary conditions, with a focus on improving disease control and delaying progression in higher-risk patients. These trials examine whether newer treatment combinations can strengthen standard care.

Studies in high-risk prostate cancer and recurrent disease
Trials using biomarker-driven strategies to guide treatment choice
Research aimed at improving progression-free and metastasis-free outcomes

The research portfolio reflects a broader interest in male urogenital diseases and more tailored treatment planning.

Cardiovascular Disease and Heart Failure Trials

Clinical research at this hospital includes several studies in cardiovascular diseases, especially heart failure, thrombotic complications, and outcomes after acute cardiac events. The trials are designed to test whether newer therapies can reduce hospitalizations, improve recovery, and lower the risk of cardiovascular death.

Studies in heart failure with preserved ejection fraction and related metabolic conditions
Research on left ventricular thrombosis after acute myocardial infarction
Trials evaluating better strategies for preventing complications and improving patient outcomes

This area highlights an ongoing effort to improve care for patients with complex cardiac disease and overlapping comorbidities.

Colorectal Cancer and Other Solid Tumors

The oncology program includes studies in colorectal cancer and other solid tumors, focusing on whether new treatment approaches can improve disease control after surgery or in advanced disease. These trials aim to strengthen treatment effectiveness and extend the time before recurrence or progression.

Research in metastatic colorectal cancer and stage II-III disease
Trials targeting tumors with specific molecular alterations
Studies assessing whether treatment can better prevent recurrence and improve survival

The work contributes to broader neoplasm research by matching treatment strategies more closely to tumor biology.

Nervous System Diseases and Infection-Related Studies

Sankt Gorans Sjukhus also participates in trials outside oncology, including nervous system diseases and infectious conditions. These studies are designed to improve recovery after acute neurological events and to evaluate treatments that may limit injury or relieve symptoms.

Research in acute ischemic stroke aimed at improving functional recovery
Studies of vestibular neuritis to reduce dizziness and related symptoms
Infection-focused trials in tick-borne encephalitis and antibiotic-resistant urinary infections

Together, these projects show a broader interest in both neurology and virus diseases, as well as practical improvements in infection management.

Hematologic Malignancies and Immune-Related Cancers

The site’s research portfolio includes studies in hematologic diseases, particularly lymphomas and acute leukemia, with some trials also touching on broader cancer biology. These projects are focused on improving treatment response and identifying more effective options for patients with aggressive or difficult-to-treat disease.